ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
2019 · Journal of Crohn s and Colitis · 1,315 citations
https://doi.org/10.1093/ecco-jcc/jjz180
B
Bernd Bokemeyer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
308
Papers
6.9K
Citations
32
h-index
77
i10-index
Bernd Bokemeyer is an academic researcher from Kielce University of Technology. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Eosinophilic Esophagitis. The author has an h-index of 32, co-authored 262 publications.
ORCID: 0000-0003-2016-6991Papers by this author
worksECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
2019 · Journal of Crohn s and Colitis · 1,095 citations
https://doi.org/10.1093/ecco-jcc/jjz187
Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis
2009 · Clinical Gastroenterology and Hepatology · 152 citations
https://doi.org/10.1016/j.cgh.2009.04.004
Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population
2018 · PLoS Genetics · 94 citations
https://doi.org/10.1371/journal.pgen.1007329
Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn’s Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study
2023 · Inflammatory Bowel Diseases · 18 citations
https://doi.org/10.1093/ibd/izad138
Rates of clinical remission and inadequate response to advanced therapies among patients with ulcerative colitis in Germany
2023 · International Journal of Colorectal Disease · 10 citations
https://doi.org/10.1007/s00384-023-04397-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat